FDA Rejects New Diabetes Drug
Regulators have rejected a new diabetes drug, Bydureon, made by Eli Lilly & Company and Amylin Pharmaceuticals, the companies said late Tuesday. The companies said that the Food and Drug Administration had asked them to perform a study to test for …
Amylin says FDA wants more testing on Bydureon
FDA seeks more data on Amylin, Lilly diabetes drug
Will the FDA Approve Bydureon?
View full post on Health – Google News